<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250408065257N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-12</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of Central and Peripheral Stimulation Combined with Exercise in Women with Patellofemoral Pain Syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Synergistic Effects of transcranial Direct Current Stimulation, transcranial Alternative Current Stimulation and Neuromuscular Electrical Stimulation Combined with Exercise Therapy on Clinical Outcomes and Electroencephalographic Activity in Women with Patellofemoral Pain Syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/82781</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: All Eligible Patients will be Randomly Assigned Using Block Randomization with Blocks of Size 6, Equally Distributed into Three Groups (with an Allocation Ratio of 1:1:1): NMES+EX, tDCS+EX, and tACS+EX. The Group Allocation for Each Participant will be Concealed Using Sealed Envelopes, Blinding description: This study is double-blinded. Both participants and the outcome assessor will be blinded to the group allocation. All assessments will be performed by a physiotherapist who is independent of the research team and will only work with participant codes. In the tDCS and tACS groups, 20-minute brain stimulation is delivered prior to the exercise in a seated and relaxed position, using a constant intensity of 2 mA. Electrode placement is identical in both groups. The device interface and settings are indistinguishable, and the display screen is masked to prevent revealing the type of current. Participants are informed that the study involves different types of brain stimulation without specifying which type. In the NMES group, electrical stimulation is applied simultaneously with strengthening exercises, which makes complete blinding of participants in this group not feasible. However, the assessor remains blinded throughout and is not involved in any part of the intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>Patellofemoral Pain Syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: NMES and Exercise Therapy. Intervention 2: Intervention group: tDCS and  Exercise Therapy. Intervention 3: Intervention group: tACS and Exercise Therapy.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Individuals interested in receiving more information can contact the person responsible for the scientific correspondence of the study via email at karimpour-s@razi.tums.ac.ir.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Samira Karimpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 24 &amp; 26, Rahmati Bahambari Ave., valiasr Sq.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1594733711</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>karimpour-s@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Samira Karimpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 24 &amp; 26, Rahmati Bahambari Ave., valiasr Sq.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1594733711</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>karimpour-s@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women Aged Between 18 and 35 Years
History of Unilateral or Bilateral Pain Around or Behind the Patella, Exacerbated by at Least Two of the Following Activities: Squatting, Going Up or Down Stairs, or Prolonged Sitting with Knees Bent
Tenderness to Palpation Over the Medial or Lateral Facets of the Patella
Pain During Isometric Contraction of the Quadriceps Against Resistance Applied Above the Patella, and Pain During Resisted Knee Extension at Various Degrees of Flexion
Non-traumatic Onset of Symptoms
Patellofemoral Joint Pain for at Least the Past 3 Months
Minimum Literacy Level Equivalent to Completion of Middle School</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of Knee Injuries such as Meniscal, Tendon, or Ligament Damage
History of Patellar Subluxation or Dislocation
Any Condition Affecting Other Joints Involving the Lower Limbs or the Back
History of Fractures in the Spine or Lower Limbs
History of Surgery or Arthroscopy in any of the Lower Limb Joints
History of Head Trauma, Neurological Disorders, or Mental Health Issues
Contraindications for Neuromodulation such as Pregnancy, Presence of Metal Implants, Epilepsy, History of Skull Fracture, or Cardiac Pacemaker</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: NMES and Exercise Therapy</i_keyword>
      <i_keyword>Intervention group: tDCS and  Exercise Therapy</i_keyword>
      <i_keyword>Intervention group: tACS and Exercise Therapy</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain Intensity on Visual Analogue Scale. Timepoint: Pain intensity will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Functional Activity Level. Timepoint: Functional Activity Level will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Kujala Questionnaire.</sec_outcome>
      <sec_outcome>Dynamic Balance. Timepoint: Dynamic Balance will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Y-balance test.</sec_outcome>
      <sec_outcome>Functional Performance. Timepoint: Functional Performance will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Step-Down test.</sec_outcome>
      <sec_outcome>Mean relative power of the EEG frequency bands. Timepoint: Mean relative power of the EEG frequency bands will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Recording with an EEG device and measurement using sLORETA software.</sec_outcome>
      <sec_outcome>Mean absolute power of the EEG frequency bands. Timepoint: Mean absolute power of the EEG frequency bands will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention. Method of measurement: Recording with an EEG device and measurement using sLORETA software.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-04-24</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central Building of Tehran University of Medical Sciences, Corner of Ghods St., Keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
